Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Epeius Pharma
Epeius Pharma Overview
Epeius Pharma is a cell and gene therapy company developing biological vehicles for the delivery of therapeutic proteins into the central nervous system. Epeius Pharma's platform could allow for an effective and scalable strategy for disease medication in neurodevelopmental and neurological pathologies that could benefit from direct neuron protein replacement treatments. Its first target indication will be Rett syndrome.
Epeius Pharma was founded based on the joint research efforts of Professor Oded Rechavi and Shahar Bracha of the Department of Neurobiology, Wise Faculty of Life Sciences & Sagol School of Neuroscience, Tel Aviv University, and Dr. Lilach Sheiner, senior lecturer and research fellow at the Wellcome Center of Integrative Parasitology, University of Glasgow. It was licensed from Ramot, the technology transfer company of Tel Aviv University and Glasgow University.
FutuRx, together with Ramot at Tel-Aviv University and Glasgow University, Launches Epeius pharma to develop treatments for complex neurological diseases
FutuRx, together with Ramot at Tel-Aviv University and Glasgow University, Launches Epeius pharma to develop treatments for complex neurological diseases
#Partners
View other companies you might be interested in
Epeius Pharma Team
No Data, yet.
Sorry, no content found under this section.
View other companies you might be interested in
Connect with
What is the reason for connecting? *
Your company *
Company website (recommended)
Please enter a valid website
Your organization type *
Please enter a valid organization type
Your position *
Add invitation message
0/300
Sending invitation...
Invitation sent
You will be able to start a conversation once [Name] accepts it.